Hancke C, Flytlie K
This retrospective analysis reviewed 470 patients who had received EDTA chelation treatment for moderate to severe arteriosclerosis. Before treatment, 92 of these patients had already been referred for surgical evaluation due to the severity of their condition. The researchers tracked objective cardiovascular outcomes before and after chelation.
80% of patients showed objective improvement in cardiovascular condition. Of the 92 patients previously referred for surgery, only 10 ultimately required it after EDTA treatment — suggesting chelation may reduce the need for surgical intervention in a meaningful proportion of patients.
Bottom line — In this retrospective cohort of 470 patients with moderate to severe arteriosclerosis, 80% showed objective cardiovascular improvement following EDTA chelation, and only 10 of the 92 patients previously referred for surgery ultimately required it. The study is observational rather than randomized — its strength is the size of the cohort and the objective outcome measures, not causal proof. It is best read as a clinical signal that helped motivate later randomized trials.